Treatment for gout may include reducing your consumption of these offending foods. While it might be surprising to you, ...

XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

XORTX Therapeutics (XRTX) announces the launch of a new late stage program to treat gout. The new drug development program – XRx-026 – will ...

Medscape Medical News, November 25, 2024 ACR 2024 Diabetes Drug Class May Reduce Need for Gout Medications Real-world data show reduction in use of urate-lowering therapy among people with type 2 ...

It has been awarded a fast-track review by the FDA, which Sobi said “underscores the urgent need for new treatment options for patients with chronic refractory gout.” If approved, it will ...

The refractory gout market is growing because of the rising prevalence of gout brought on by aging populations and changes in ...

Comorbidities may affect the disease severity and treatment patterns. We describe the main characteristics of gout patients, gout-related treatment patterns and prevalent comorbidities in a ...